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Background
Inflammation is a vital process induced by microbial
infection or tissue injury. The main function of inflam-
mation is to resolve the infection or repair the damage
and return the body to a state of homeostasis. Acute
inflammation can induce signals that result in two main
functions: 1) initiation of an inflammatory cascade that
helps limits the infection and 2) activation of the immune
response. In this study we determined the impact of the
nature and magnitude of acute inflammation on the host
anti-tumor activity against Ehrlich Ascites cancer cell
(EAC) line as a model system which forms either perito-
neal ascites upon intraperitoneal injection.
Design
Different inflammatory signals, including agonists for toll-
like receptor (TLR) 2 (zymosan) and TLR3 agonist (poly
(I:C) or its clinical grade Hiltonol®), complete Freund’s
adjuvant (CFA), and incomplete Freunds Adjuvant (IFA),
and BCG from Bacillus calmatte (TLR9 agonist) were used
to induce acute inflammation 1 day after i.p. challenge
with EAC.
Results
We found that Hiltonol®, poly (I:C), IFA, CFA, and BCG
induced inflammatory cells associated with anti-tumor
activity that resulted in significant decrease in the tumor
growth measured by the total number of tumor cells after
7 days of tumor challenge. Of interest, among the test
TLR agonists both poly(I:C) and Hiltonol® (TLR3 agonist)
showed the highest anti-tumor effects.
Conclusions
Provision of the proper inflammatory signal with optimally
defined magnitude and duration during cancer growth will
induce inflammatory cells with potent anti-tumor
responses leading to significant decreases in tumor
growth.
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